At the AGM on April 19th, Daniela Bosshardt-Hengartner was elected to investiere.ch’s board of directors. She has a background as a pharmacist with a masters degree from ETH. Daniela has extensive board experience with large as well as small companies and has also worked in private equity and as a management consultant in the healthcare sector. She sat on the board of Nobel Biocare, a market leader in dental implants, from 2010 until 2014 and sits on the board of Vifor Pharma, a leading specialty pharma company in nephrology and on the board of Galenica, the largest operator of pharmacies in Switzerland.
“We are thrilled that Daniela is joining us,” states Lukas Weber, co-founder and chairman of investiere.ch. “With her experience and skillset she complements our board perfectly and is the ideal choice to help us reach the next level.”
investiere.ch has successfully closed over 50 financing rounds and is one of the leading startup investors in Switzerland and one of the most internationally renowned Swiss fintech companies.
“investiere has achieved a number of key milestones recently and this appointment is yet another example of our momentum and growth,” explains investiere co-founder Steffen Wagner. “In addition to closing a Serie B financing round in summer in which Zürcher Kantonalbank participated, we also recently entered into a partnership with the pension fund Nest that is now systematically investing in Swiss startups through investiere.”
“I am excited to join the investiere board of directors and look forward to supporting a great team, who has established an impressive platform” said Daniela Bosshardt. “The recent successes are a further confirmation of investiere.ch’s potential.”